Cargando…
Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
The effect of intraperitoneal (i.p.) injection of recombinant human interleukin-1 beta (rhIL-1 beta) was studied in three i.p. nude mouse xenograft models of human ovarian cancer (HU, OS, and LA). Intraperitoneal rhIL-1 beta administration led to a dose dependent replacement of peritoneal ascitic tu...
Autores principales: | Malik, S. T., East, N., Boraschi, D., Balkwill, F. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977379/ https://www.ncbi.nlm.nih.gov/pubmed/1586593 |
Ejemplares similares
-
Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF.
por: Malik, S. T., et al.
Publicado: (1991) -
Intraperitoneal Rupture of Ovarian Cysts
por: Das, Kedarnath
Publicado: (1901) -
Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts.
por: Pratesi, G., et al.
Publicado: (1995) -
Snapshot in surgery: intraperitoneal encapsulated fat necrosis
por: Oh, Han Boon, et al.
Publicado: (2015) -
Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
por: Minor, David R., et al.
Publicado: (2017)